There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests
arstechnica.com
In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.

In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.

  • baines@lemmy.cafeEnglish
    6·
    6 days ago

    if behavior or biology got you there why is anyone surprised that you need to keep on the drug?